Here are the 10-K annual reports from Genworth Financial, Inc. (GNW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow GNW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GNW filings page.
Genworth Financial outlines a diversified insurance platform built around three areas: Enact mortgage insurance, a Closed Block of legacy life, annuity and long-term care, and newer CareScout aging‑care businesses.
Enact, which remains majority‑owned and consolidated, focuses on U.S. private mortgage insurance and returned $407 million of capital to Genworth Holdings in 2025. Genworth is using these funds, alongside cash flow, to back growth and capital management, including a share repurchase program under which it has bought back $828 million of common stock since 2022, within a current authorization of up to $350 million.
CareScout is central to Genworth’s growth plans. CareScout Services is building a nationwide network of roughly 790 home‑care providers and added senior living reach through the October 2025 acquisition of Seniorly. CareScout Insurance launched a new individual long‑term care product, Care Assurance, available in 40 states by February 2026, with conservative pricing and access to CareScout’s quality network.
The Closed Block legacy subsidiaries no longer write new life, annuity or GLIC long‑term care policies, but continue servicing in‑force business and pursuing multi‑year in‑force rate actions. From 2012 to 2025, approved long‑term care rate increases and benefit reductions produced an estimated cumulative economic benefit of $34.5 billion on a net present value basis, supporting the aim of keeping these entities self‑sustaining.
Genworth emphasizes enterprise risk management, reinsurance and regulatory capital. Enact remains in compliance with PMIERs and state risk‑to‑capital limits, and its main subsidiary EMICO holds strong financial strength ratings, including an S&P rating of A- and Moody’s A2. Legacy life subsidiaries carry weaker A.M. Best ratings, but their risk‑based capital ratios exceed regulatory action thresholds. As of June 30, 2025, non‑affiliate holders owned common equity with an aggregate market value of about $3.1 billion, and as of February 24, 2026, there were 387,611,047 common shares outstanding.